Wearable Subcutaneous Drug Delivery
|出版商||Greystone Research Associates||商品編碼||675285|
|出版日期||內容資訊||英文 90 Pages
|穿戴式皮下藥物輸送 Wearable Subcutaneous Drug Delivery|
|出版日期: 2018年08月13日||內容資訊: 英文 90 Pages||
本報告提供穿戴式皮下 (SC) 藥物輸送市場相關調查，主要的市場區隔，市場動態，及市場人口統計，穿戴式藥物遞輸系統的治療需求促進因素，主要的設計要素，材料選擇的問題，技術、市場發展的問題，目前市場情況，市場領導，及今後展望等相關分析。
As new drugs become available for the treatment of an expanding list of health conditions, drug developers have increasingly pursued packaging and delivery options that simplify the administration process and increase the efficiency and reliability with which the drug can be introduced into the patient. For injectable drugs, this pursuit has led to an accelerated evolution in injection device design, creating new opportunities and choices for drug marketers. As the administration of injectables moves increasingly from practitioner offices and healthcare facilities to patient homes, decisions regarding as-supplied packaging that were once considered boilerplate have moved to the early stages of the development process. A wide spectrum of device attributes, including form factor, device-patient interaction, security and safety, dosing, activation, off-device communication, and drug formulation factors have been incorporated into drug injection devices. Over time, these initiatives will come to be expected by patients in injectable drugs.